Microplasmin-induced posterior vitreous detachment affects vitreous oxygen levels

Retina

Volumn 27, Issue 8, 2007, Pages 1090-1096

  Quiram, Polly A ^a,c   Leverenz, Victor R ^b   Baker, Robert M ^b   Dang, Loan ^b   Giblin, Frauk J ^b   Trese, Michael T ^a  

^a ASSOCIATED RETINAL CONSULTANTS   (United States)

^b OAKLAND UNIVERSITY   (United States)

^c WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIDASE; OXYGEN; PLASMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAT; CONTROLLED STUDY; FACE MASK; GUINEA PIG; LIQUEFACTION; NONHUMAN; OXYGEN CONCENTRATION; RAT; RETINA BLOOD FLOW; RETINA FOVEA; SCANNING ELECTRON MICROSCOPY; SENSOR; STATISTICAL SIGNIFICANCE; VITREOUS BODY DETACHMENT;

ANIMALS; CATS; FIBRINOLYTIC AGENTS; GUINEA PIGS; HYALURONOGLUCOSAMINIDASE; INJECTIONS; MICROSCOPY, ELECTRON, SCANNING; NEOVASCULARIZATION, PHYSIOLOGIC; OXYGEN; PEPTIDE FRAGMENTS; PLASMIN; RATS; RATS, INBRED BN; RETINA; VITREOUS BODY; VITREOUS DETACHMENT;

EID: 37349005820     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3180654229     Document Type: Article

References (29)

1. Sebag J. Diabetic vitreopathy. Ophthalmology 1996;103:205-206.
2. Russell SR, Hageman GS. Optic disc, foveal, and extrafoveal damage due to surgical separation of the vitreous. Arch Ophthalmol 2001;119:1653-1658.
3. Sebag J. Pharmacologic vitreolysis. Retina 1998;18:1-3.
4. Trese MT. Enzymatic vitreous surgery Semin. Ophthalmology 2000;15:116-121.
5. Hermel M, Schrage NF. Efficacy of plasmin enzymes and chondroitinase ABC in creating posterior vitreous separation in the pig: a masked, placebo-controlled in vivo study. Graefes Arch Clin Exp Ophthalmol 2007;245:399-406.
6. Sebag J. Molecular biology of pharmacologic vitreolysis. Trans Am Ophthalmol Soc 2005;103:473-494.
7. Tezel TH, Del Priore LV, Kaplan HJ. Posterior vitreous detachment with Dispase. Retina 1998;8:7-15.
8. Staubach F, Nober V, Janknecht P. Enzyme-assisted vitrectomy in enucleated pig eyes: a comparison of hyaluronidase, chondroitinase, and plasmin. Curr Eye Res 2004;29:261-268.
9. Nagai N, Demarsin E, Van Hoef B, et al. Recombinant human microplasmin: production and potential therapeutic properties. Thromb Haemost 2003;1:307-313.
10. Wang ZL, Zhang X, Xun X, et al. PVD Following plasmin but not hyaluronidase: implications for combination pharmacologic vitreolysis therapy. Retina 2005;25:35-43.
11. Hikichi T, Kado M, Yoshida A. Intravitreal injection of hyaluronidase cannot induce posterior vitreous detachment in the rabbit. Retina 2000;20:195-198.
12. Gandorfer A, Rohleder M, Sethi C, et al. Posterior vitreous detachment induced by microplasmin. Invest Ophthalmol Vis Sci 2004;45:641-647.
13. Li X, Shi X, Fan J. Posterior vitreous detachment with plasmin in the isolated human eye. Graefes Arch Clin Exp Ophthalmol 2002;240:56-61.
14. Holekamp NM, Shui YB, Beebe DC. Vitrectomy surgery increases oxygen exposure to the lens: a possible mechanism for nuclear cataract formation. Am J Ophthalmol 2005;139:302-310.
15. Grigorian R, Bhagat N, Lanzetta P, et al. Pars plana vitrectomy for refractory diabetic macular edema. Semin Ophthalmol 2003;18:116-120.
16. Recchia FM, Ruby AJ, Carvalho Reahia CA. Pars plana vitrectomy with removal of the internal limiting membrane in the treatment of persistent diabetic macular edema. Am J Ophthalmol 2005;139:447-454.
17. Gotzaridis IV, Lit IS, D'Amico DJ. Progress in vitreoretinal surgery for proliferative diabetic retinopathy. Semin Ophthalmol 2001;16:31-40.
18. Rosenblatt BJ, Shah GK, Sharma S, et al. Pars plana vitrectomy with internal limiting membranectomy for refractory diabetic macular edema without a taut posterior hyaloid. Graefes Arch Clin Exp Ophthalmol 2005;243:20-25.
19. Sakuma T, Tanuka M, Mizota A, et al. Safety of in vivo pharmacologic vitreolysis with recombinant microplasmin in rabbit eyes. Invest Ophthalmol Vis Sci 2005;46:3295-3299.
20. Gandorfer A, Putz E, Welge-Lussen U, et al. Ultrastructure of the vitreoretinal interface following plasmin assisted vitrectomy. Br J Ophthalmol 2001;85:6-10.
21. Verstraeten TC, Chapman C, Hartzer M, et al. Pharmacologic induction of posterior vitreous detachment in the rabbit. Arch Ophthalmol 1993;111:849-854.
22. Yu DY, Cringle SJ. Oxygen distribution and consumption within the retina in vascularised and avascular retinas and in animal models of retinal disease. Prog Retin Eye Res 2001;20:175-208.
23. Trese MT. Enzymatic-assisted vitrectomy. Eye 2002;16:365-368.
24. Margherio AR, Margherio RR, Hartzer M, et al. Plasmin enzyme-assisted vitrectomy in traumatic pediatric macular holes. Ophthalmology 1998;105:1617-1620.
25. Sebag J, Ansari RR, Suh KI. Pharmacologic vitreolysis with microplasmin increases vitreous diffusion coefficients. Graefes Arch Clin Exp Ophthalmol 2007;245:576-580.
26. Patel JL, Tombren-Tink J, Hykin PG, et al. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles. Exp Eye Res 2006;82:798-806.
27. Avery RL, Pearlman J, Pieramici DJ, et al. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 2006;113:1695.e1-1615.
28. Birol G, Budzynlski E, Wnagsa-Wirawan ND, et al. Hyperoxia promotes electroretinogram recovery after retinal artery occlusion in cats. Invest Ophthalmol Vis Sci 2004;45:3690-3696.
29. van Eeden PE, Tee LB, Lukehurst S. Early vascular and neuronal changes in a VEGF transgenic mouse model of retinal neovascularization. Invest Ophthalmol Vis Sci 2006;47:4638-4645.